Antibody Responses and Clinical Outcomes in Adults Hospitalized with Severe COVID-19: A Post hoc Analysis of LOTUS China Trial

BACKGROUND: The characteristics of neutralizing antibodies (NAbs) and antibody against major antigen proteins related to clinical outcomes in severe COVID-19 patients were still less known METHODS: The neutralizing antibodies (NAbs) and antibodies targeting nucleocapsid (N), spike protein (S), and t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Ren, Lili, Fan, Guohui, Wu, Wenjuan, Guo, Li, Wang, Yeming, Li, Xia, Wang, Conghui, Gu, Xiaoying, Li, Caihong, Wang, Ying, Wang, Geng, Zhou, Fei, Liu, Zhibo, Ge, Qing, Zhang, Yi, Li, Hui, Zhang, Lulu, Xu, Jiuyang, Wang, Chen, Wang, Jianwei, Cao, Bin
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Major Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499517/
https://ncbi.nlm.nih.gov/pubmed/32840287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa1247
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars